Six debt funding proposals and it's ZYLs job to manage the company. I think "the investor" has to be bringing something pretty special to the table to justify the PSA.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025